Keryx Biopharmaceuticals : Termination of SUN-MACRO Phase 4 Trial

March 27, 2008 - Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced today that following a Drug Safety and Monitoring Committee (DSMC) review of the SUN-MACRO Phase 4 trial of Sulonex(TM) (sulodexide oral gelcap), the Company has decided to terminate the study and cease further development of Sulonex... Keryx's Press Release -